Pande Atul
SEC CIK 1643071 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Dir | 118.2K | $123.9K | $1.14M | 20 | 2021-08-13 | 2026-08-28 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Immunovant, Inc. | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale+OE | $43.27 | -1,500 | 116.7K | -1% | -$64.9K |
| DT | 2026-07-24 17:59 | 2026-07-24 | IMVT | Immunovant, Inc. | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-07-24 17:59 | 2026-07-24 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale+OE | $39.80 | -1,500 | 116.7K | -1% | -$59.7K |
| DT | 2026-06-26 19:43 | 2026-06-26 | IMVT | Immunovant, Inc. | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-06-26 19:43 | 2026-06-26 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale+OE | $38.01 | -1,500 | 116.7K | -1% | -$57.0K |
| DT | 2026-06-16 16:03 | 2026-06-15 | IMVT | Immunovant, Inc. | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-06-16 16:03 | 2026-06-15 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale+OE | $34.02 | -1,500 | 116.7K | -1% | -$51.0K |
| DT | 2026-05-20 21:22 | 2026-05-20 | IMVT | Immunovant, Inc. | Pande Atul | Dir | M - OptEx | $8.43 | +6,000 | 122.7K | +5% | +$50.6K |
| DT | 2026-05-20 21:22 | 2026-05-20 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale+OE | $32.00 | -6,000 | 116.7K | -5% | -$192.0K |
| D | 2026-04-09 16:25 | 2026-04-07 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +13.9K | 116.7K | +13% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +16.2K | 102.9K | +19% | $0 |
| 2024-12-04 | 2024-12-02 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale | $28.54 | -7,750 | 86.7K | -8% | -$221.2K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +11.3K | 94.4K | +14% | $0 |
| M | 2023-12-05 | 2023-12-01 | IMVT | Immunovant, Inc. | Pande Atul | Dir | S - Sale | $39.73 | -12.3K | 83.2K | -13% | -$490.7K |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +12.5K | 95.5K | +15% | $0 |
| I | 2022-10-04 | 2022-09-30 | IMVT | Immunovant, Inc. | Pande Atul | Dir | P - Purchase | $5.60 | +15.0K | 20.0K | +300% | +$84.0K |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +21.1K | 83.0K | +34% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Immunovant, Inc. | Pande Atul | Dir | A - Grant | $0.00 | +21.7K | 61.9K | +54% | $0 |
| I | 2021-08-16 | 2021-08-13 | IMVT | Immunovant, Inc. | Pande Atul | Dir | P - Purchase | $7.98 | +5,000 | 45.2K | +12% | +$39.9K |
Purchase Sale Sale after option exercise All abbreviations